NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
$350,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which...
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
$1,050,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), ...
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
$350,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as d...
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 01/28/2026
DUE: 05/07/2026
The purpose of this notice of funding opportunity (NOFO) is to support the investigation of HIV-1 Envelope (Env) cell surface expression, the structural mechanism of biologic-mediated cell killing, an...
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
$200,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/16/2027
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through ...
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/16/2027
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through ...
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
HHS-NIH11
POSTED: 12/01/2023
UPDATED: 12/01/2023
DUE: 01/07/2027
The NEI uses this U44 Notice of Funding Opportunity to support SBIR grant applications from small business concerns (SBCs) that propose to implement investigator-initiated, early-stage clinical trials...
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
$1,000,000
HHS-NIH11
POSTED: 08/31/2026
UPDATED: 08/31/2026
DUE: 06/23/2028
This Notice of Funding Opportunity (NOFO) supports transdisciplinary research teams seeking to develop mechanistic, biologically grounded explanations of how neural circuits and their cellular buildin...
Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 08/31/2026
UPDATED: 08/31/2026
DUE: 10/02/2028
This Notice of Funding Opportunity (NOFO) supports "mature" resources at synchrotron facilities that provide user access to X-ray beamlines for static and dynamic imaging of biological systems ranging...
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11
POSTED: 08/31/2026
UPDATED: 08/31/2026
DUE: 06/16/2028
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on u...